Martin Hutchings (M Hutchings)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 32

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Blood advances

Blood

JCO clinical cancer informatics

Rigshospitalet

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Rigshospitalet Apr 01 2012

Denmark

Senior consultant :: Department of Haematology and Phase 1 Unit

Publications

Julie Haugaard Vandtved, Andreas Kiesbye Øvlisen, Joachim Bæch, Ulla Møller Weinreich, Marianne Tang Severinsen, Eva Futtrup Maksten, Lasse Hjort Kyneb Jakobsen, Ingrid Glimelius, Peter Kamper, Martin Hutchings, Lena Specht, Rasmus Bo Dahl-Sørensen, Jacob Haaber Christensen, Tarec Christoffer El-Galaly
Pulmonary diseases in patients with classical Hodgkin lymphoma relative to a matched background population: A Danish national cohort study. British journal of haematology (2024)
Mats Jerkeman, Arne Kolstad, Martin Hutchings, Annika Pasanen, Leo Meriranta, Carsten Utoft Niemann, Rasmus Rask Kragh Jørgensen, Tarec Christoffer El-Galaly, Jon Riise, Sirpa Leppa, Jacob Haaber Christensen, Kristina Sonnevi, Lone Bredo Pedersen, Karin Fahl Wader, Ingrid Glimelius
MRD-driven treatment with venetoclax-R2 in mantle cell lymphoma: the Nordic Lymphoma Group MCL7 VALERIA trial. Blood advances 8 (2) (2024)
Massimo Federico, Wouter J Plattel, Martin Hutchings, Yana Stepanishyna, Catherine Fortpied, Marc André
Reply to T. Vassilakopoulos et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Rasmus Rask Kragh Jørgensen, Fanny Bergström, Sandra Eloranta, Marianne Tang Severinsen, Knut B Smeland, Alexander Fosså, Jacob Haaber Christensen, Martin Hutchings, Rasmus Bo Dahl-Sørensen, Peter Kamper, Ingrid Glimelius, Karin E Smedby, Susan K Parsons, Angie Mae Rodday, Matthew John Maurer, Andrew M Evens, Tarec C El-Galaly, Lasse Hjort Jakobsen
Machine Learning-Based Survival Prediction Models for Progression-Free and Overall Survival in Advanced-Stage Hodgkin Lymphoma. JCO clinical cancer informatics 8 (2024)
Sára Rossetti, Sidsel Jacobsen Juul, Marleen A E van der Kaaij, Catherine Fortpied, Paul Meijnders, Berthe M P Aleman, John M M Raemaekers, Hanneke C Kluin-Nelemans, Michele Spina, Christophe Fermé, Richard Greil, Olivier Casasnovas, Aspasia Stamatoullas, Wouter J Plattel, Martin Hutchings, Maja Vestmø Maraldo
Relationships, marriage, and partner abandonment among Hodgkin lymphoma survivors treated in nine EORTC-GELA Lymphoma Group trials. Leukemia & lymphoma (2024)
Rasmus Rask Kragh Jørgensen, Fanny Bergström, Sandra Eloranta, Marianne Tang Severinsen, Knut B Smeland, Alexander Fosså, Jacob Haaber Christensen, Martin Hutchings, Rasmus Bo Dahl-Sørensen, Peter Kamper, Ingrid Glimelius, Karin E Smedby, Susan K Parsons, Angie Mae Rodday, Matthew John Maurer, Andrew M Evens, Tarec C El-Galaly, Lasse Hjort Jakobsen
Machine Learning-Based Survival Prediction Models for Progression-Free and Overall Survival in Advanced-Stage Hodgkin Lymphoma. JCO clinical cancer informatics 8 (2024)
Mats Jerkeman, Arne Kolstad, Martin Hutchings, Annika Pasanen, Leo Meriranta, Carsten Utoft Niemann, Rasmus Rask Kragh Jørgensen, Tarec Christoffer El-Galaly, Jon Riise, Sirpa Leppa, Jacob Haaber Christensen, Kristina Sonnevi, Lone Bredo Pedersen, Karin Fahl Wader, Ingrid Glimelius
MRD-driven treatment with venetoclax-R2 in mantle cell lymphoma: the Nordic Lymphoma Group MCL7 VALERIA trial. Blood advances 8 (2) (2024)
Rasmus Rask Kragh Jørgensen, Fanny Bergström, Sandra Eloranta, Marianne Tang Severinsen, Knut B Smeland, Alexander Fosså, Jacob Haaber Christensen, Martin Hutchings, Rasmus Bo Dahl-Sørensen, Peter Kamper, Ingrid Glimelius, Karin E Smedby, Susan K Parsons, Angie Mae Rodday, Matthew John Maurer, Andrew M Evens, Tarec C El-Galaly, Lasse Hjort Jakobsen
Machine Learning-Based Survival Prediction Models for Progression-Free and Overall Survival in Advanced-Stage Hodgkin Lymphoma. JCO clinical cancer informatics 8 (2024)
Jennifer L Crombie, Tara Graff, Lorenzo Falchi, Yasmin H Karimi, Rajat Bannerji, Loretta J Nastoupil, Catherine Thieblemont, Renata Ursu, Nancy L Bartlett, Victoria R Nachar, Jonathan Weiss, Jane Osterson, Krish Patel, Joshua D Brody, Jeremy S Abramson, Matthew A Lunning, Nirav N Shah, Ayed Ayed, Manali Kamdar, Benjamin M Parsons, Paolo Caimi, Ian W Flinn, Alex F Herrera, Jeff P Sharman, Marshall McKenna, Philippe Armand, Brad S Kahl, Sonali M Smith, Andrew D Zelenetz, L Elizabeth Elizabeth Budde, Martin Hutchings, Tycel Jovelle Phillips, Michael J Dickinson
Consensus Recommendations on the Management of Toxicity Associated with CD3xCD20 Bispecific Antibody Therapy. Blood (2024)
Massimo Federico, Wouter J Plattel, Martin Hutchings, Yana Stepanishyna, Catherine Fortpied, Marc André
Reply to T. Vassilakopoulos et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (18) (2024)
Mats Jerkeman, Arne Kolstad, Martin Hutchings, Annika Pasanen, Leo Meriranta, Carsten Utoft Niemann, Rasmus Rask Kragh Jørgensen, Tarec Christoffer El-Galaly, Jon Riise, Sirpa Leppa, Jacob Haaber Christensen, Kristina Sonnevi, Lone Bredo Pedersen, Karin Fahl Wader, Ingrid Glimelius
MRD-driven treatment with venetoclax-R2 in mantle cell lymphoma: the Nordic Lymphoma Group MCL7 VALERIA trial. Blood advances 8 (2) (2024)
Mats Jerkeman, Arne Kolstad, Martin Hutchings, Annika Pasanen, Leo Meriranta, Carsten Utoft Niemann, Rasmus Rask Kragh Jørgensen, Tarec Christoffer El-Galaly, Jon Riise, Sirpa Leppa, Jacob Haaber Christensen, Kristina Sonnevi, Lone Bredo Pedersen, Karin Fahl Wader, Ingrid Glimelius
MRD-driven treatment with venetoclax-R2 in mantle cell lymphoma: the Nordic Lymphoma Group MCL7 VALERIA trial. Blood advances 8 (2) (2024)
Julie Haugaard Vandtved, Andreas Kiesbye Øvlisen, Joachim Bæch, Ulla Møller Weinreich, Marianne Tang Severinsen, Eva Futtrup Maksten, Lasse Hjort Kyneb Jakobsen, Ingrid Glimelius, Peter Kamper, Martin Hutchings, Lena Specht, Rasmus Bo Dahl-Sørensen, Jacob Haaber Christensen, Tarec Christoffer El-Galaly
Pulmonary diseases in patients with classical Hodgkin lymphoma relative to a matched background population: A Danish national cohort study. British journal of haematology 205 (2) (2024)
Massimo Federico, Wouter J Plattel, Martin Hutchings, Yana Stepanishyna, Catherine Fortpied, Marc André
Reply to T. Vassilakopoulos et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (18) (2024)
Jennifer L Crombie, Tara Graff, Lorenzo Falchi, Yasmin H Karimi, Rajat Bannerji, Loretta J Nastoupil, Catherine Thieblemont, Renata Ursu, Nancy L Bartlett, Victoria Nachar, Jonathan Weiss, Jane Osterson, Krish Patel, Joshua D Brody, Jeremy S Abramson, Matthew A Lunning, Nirav N Shah, Ayed Ayed, Manali Kamdar, Benjamin Parsons, Paolo F Caimi, Ian W Flinn, Alex F Herrera, Jeffrey Sharman, Marshall McKenna, Philippe Armand, Brad S Kahl, Sonali M Smith, Andrew D Zelenetz, L Elizabeth Elizabeth Budde, Martin Hutchings, Tycel Jovelle Phillips, Michael J Dickinson
Consensus recommendations on the management of toxicity associated with CD3×CD20 bispecific antibody therapy. Blood 143 (16) (2024)
Jennifer L Crombie, Tara Graff, Lorenzo Falchi, Yasmin H Karimi, Rajat Bannerji, Loretta J Nastoupil, Catherine Thieblemont, Renata Ursu, Nancy L Bartlett, Victoria R Nachar, Jonathan Weiss, Jane Osterson, Krish Patel, Joshua D Brody, Jeremy S Abramson, Matthew A Lunning, Nirav N Shah, Ayed Ayed, Manali Kamdar, Benjamin M Parsons, Paolo Caimi, Ian W Flinn, Alex F Herrera, Jeff P Sharman, Marshall McKenna, Philippe Armand, Brad S Kahl, Sonali M Smith, Andrew D Zelenetz, L Elizabeth Elizabeth Budde, Martin Hutchings, Tycel Jovelle Phillips, Michael J Dickinson
Consensus Recommendations on the Management of Toxicity Associated with CD3xCD20 Bispecific Antibody Therapy. Blood (2024)
Mats Jerkeman, Arne Kolstad, Martin Hutchings, Annika Pasanen, Leo Meriranta, Carsten Utoft Niemann, Rasmus Rask Kragh Jørgensen, Tarec Christoffer El-Galaly, Jon Riise, Sirpa Leppa, Jacob Haaber Christensen, Kristina Sonnevi, Lone Bredo Pedersen, Karin Fahl Wader, Ingrid Glimelius
MRD-driven treatment with venetoclax-R2 in mantle cell lymphoma: the Nordic Lymphoma Group MCL7 VALERIA trial. Blood advances 8 (2) (2024)
Sidsel Jacobsen Juul, Sára Rossetti, Michal Kicinski, Marleen A E van der Kaaij, Francesco Giusti, Paul Meijnders, Berthe M P Aleman, John M M Raemaekers, Hanneke C Kluin-Nelemans, Michele Spina, Christophe Fermé, Richard Greil, René-Olivier Casasnovas, Aspasia Stamatoullas, Marc André, Fabien Le Bras, Wouter J Plattel, Michel Henry-Amar, Martin Hutchings, Maja Vestmø Maraldo
Work and education interruption in long-term Hodgkin lymphoma survivors: an analysis among patients from nine EORTC-LYSA trials. Acta oncologica (Stockholm, Sweden) (2023)
Anna Nikkarinen, Lavanya Lokhande, Rose-Marie Amini, Mats Jerkeman, Anna Porwit, Daniel Molin, Gunilla Enblad, Arne Kolstad, Riikka Katariina Räty, Martin Hutchings, Caroline E Weibull, Peter Hollander, Sara Ek, Ingrid Glimelius
Soluble CD163 predicts outcome in both chemoimmunotherapy and targeted therapy-treated mantle cell lymphoma. Blood advances (2023)
Massimo Federico, Catherine Fortpied, Yana Stepanishyna, Manuel Gotti, Richard W M van der Maazen, Caterina Cristinelli, Alessandro Re, Wouter J Plattel, Julien Lazarovici, Francesco Merli, Lena Specht, Jean Marc Schiano De Colella, Martin Hutchings, Annibale Versari, Véronique Edeline, Aspassia Stamatoullas, Theodore Girinsky, Umberto Ricardi, Berthe M P Aleman, Bart Meulemans, Sanne Tonino, John Raemaekers, Marc P E André
Long-Term Follow-Up of the Response-Adapted Intergroup EORTC/LYSA/FIL H10 Trial for Localized Hodgkin Lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Mats Jerkeman, Arne Kolstad, Martin Hutchings, Annika Pasanen, Leo Meriranta, Carsten Utoft Niemann, Rasmus Rask Kragh Jørgensen, Tarec Christoffer El-Galaly, Jon Riise, Sirpa Leppa, Jacob Haaber Christensen, Kristina Sonnevi, Lone Bredo Pedersen, Karin Fahl Wader, Ingrid Glimelius
MRD-driven treatment with venetoclax-R2 in mantle cell lymphoma: the Nordic Lymphoma Group MCL7 VALERIA trial. Blood advances (2023)
Catherine Thieblemont, Tycel Jovelle Phillips, Hervé Ghesquières, Chan Yoon Y Cheah, Michael Roost Clausen, David Cunningham, Young Rok Do, Tatyana Feldman, Robin Gasiorowski, Wojciech Jurczak, Tae Min Kim, David John Lewis, Marjolein van der Poel, Michelle Limei Poon, Mariana Cota Stirner, Nurgul Kilavuz, Christopher Chiu, Menghui Chen, Mariana Sacchi, Brian Elliott, Tahamtan Ahmadi, Martin Hutchings, Pieternella J Lugtenburg
Epcoritamab, a Novel, Subcutaneous CD3xCD20 Bispecific T-Cell-Engaging Antibody, in Relapsed or Refractory Large B-Cell Lymphoma: Dose Expansion in a Phase I/II Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Sidsel Jacobsen Juul, Michal Kicinski, Michael Schaapveld, Sára Rossetti, Berthe M P Aleman, Lifang Liu, Flora E van Leeuwen, Paul Meijnders, Augustinus D G Krol, Cécile P M Janus, Martin Hutchings, Maja Vestmø Maraldo
Comparison of outcomes between Hodgkin's lymphoma patients treated in and outside clinical trials: A study based on the EORTC-Dutch late effects cohort-linked data. European journal of haematology (2022)
Robert J Kreitman, Philippe Moreau, Farhad Ravandi, Martin Hutchings, Anas Gazzah, Anne-Sophie Michallet, Zev A Wainberg, Alexander Stein, Sascha Dietrich, Maja J A de Jonge, Wolfgang Willenbacher, Jacques De Grève, Evgeny Arons, Palanichamy Ilankumaran, Paul Burgess, Eduard Gasal, Vivek Subbiah
Dabrafenib plus trametinib in patients with relapsed/refractory BRAF V600E mutation-positive hairy cell leukemia. Blood (2022)
Luc-Matthieu Fornecker, Julien Lazarovici, Igor Aurer, René-Olivier Casasnovas, Anne-Claire Gac, Christophe Bonnet, Krimo Bouabdallah, Pierre Feugier, Lena Specht, Lysiane Molina, Mohamed Touati, Cécile Borel, Aspassia Stamatoullas, Emmanuelle Nicolas-Virelizier, Laurent Pascal, Pieternella J Lugtenburg, Nicola Di Renzo, Thierry Vander Borght, Alexandra Traverse-Glehen, Peggy Dartigues, Martin Hutchings, Annibale Versari, Michel Meignan, Massimo Federico, Marc André, null null
Brentuximab Vedotin Plus AVD for First-Line Treatment of Early-Stage Unfavorable Hodgkin Lymphoma (BREACH): A Multicenter, Open-Label, Randomized, Phase II Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Catherine Thieblemont, Tycel Jovelle Phillips, Hervé Ghesquières, Chan Yoon Y Cheah, Michael Roost Clausen, David Cunningham, Young Rok Do, Tatyana Feldman, Robin Gasiorowski, Wojciech Jurczak, Tae Min Kim, David John Lewis, Marjolein van der Poel, Michelle Limei Poon, Mariana Cota Stirner, Nurgul Kilavuz, Christopher Chiu, Menghui Chen, Mariana Sacchi, Brian Elliott, Tahamtan Ahmadi, Martin Hutchings, Pieternella J Lugtenburg
Epcoritamab, a Novel, Subcutaneous CD3xCD20 Bispecific T-Cell-Engaging Antibody, in Relapsed or Refractory Large B-Cell Lymphoma: Dose Expansion in a Phase I/II Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Andreas Kiesbye Øvlisen, Lasse Hjort Kyneb Jakobsen, Sandra Eloranta, Kristian H Kragholm, Martin Hutchings, Henrik Frederiksen, Peter Kamper, Rasmus Bo Dahl-Sørensen, Danny Stoltenberg, Caroline E Weibull, Joshua P Entrop, Ingrid Glimelius, Karin E Smedby, Christian Torp-Pedersen, Marianne Tang Severinsen, Tarec C El-Galaly
Parenthood Rates and Use of Assisted Reproductive Techniques in Younger Hodgkin Lymphoma Survivors: A Danish Population-Based Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (31) (2021)
Martin Hutchings, John Radford, Stephen M Ansell, Árpád Illés, Anna Sureda, Joseph M Connors, Alice Sýkorová, Hirohiko Shibayama, Jeremy S Abramson, Neil S Chua, Jonathan W Friedberg, Jan Kořen, Ann Steward LaCasce, Lysiane Molina, Gerald Engley, Keenan Fenton, Hina Jolin, Rachael Liu, Ashish Gautam, Andrea Gallamini
Brentuximab vedotin plus doxorubicin, vinblastine, and dacarbazine in patients with advanced-stage, classical Hodgkin lymphoma: A prespecified subgroup analysis of high-risk patients from the ECHELON-1 study. Hematological oncology 39 (2) (2021)
Martin Hutchings, Franck Morschhauser, Gloria Iacoboni, Carmello Carlo-Stella, Fritz C Offner, Anna Sureda, Gilles Andre Salles, Joaquín Martínez-Lopez, Michael Crump, Denise N Thomas, Peter N Morcos, Cristiano Ferlini, Ann-Marie E Bröske, Anton Belousov, Marina Bacac, Natalie Dimier, David J Carlile, Linda Lundberg, David Perez-Callejo, Pablo Umaña, Tom Moore, Martin Weisser, Michael J Dickinson
Glofitamab, a Novel, Bivalent CD20-Targeting T-Cell-Engaging Bispecific Antibody, Induces Durable Complete Remissions in Relapsed or Refractory B-Cell Lymphoma: A Phase I Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (18) (2021)
Jakoba Johanna Eertink, C N Burggraaff, M W Heymans, U Dührsen, Andreas Huettmann, C Schmitz, S Müller, Pieternella J Lugtenburg, Sally F Barrington, N George Mikhaeel, R Carr, S Czibor, Tamás Györke, Luca Ceriani, Emanuele Zucca, Martin Hutchings, L Kostakoglu, A Loft, S Fanti, Sanne Elisabeth Wiegers, S Pieplenbosch, R Boellaard, O S Hoekstra, Josée J M Zijlstra-Baalbergen, Henrica C W de Vet
Optimal timing and criteria of interim PET in DLBCL: a comparative study of 1692 patients. Blood advances 5 (9) (2021)
Michael J Dickinson, Javier Briones, Alex F Herrera, Eva González-Barca, Nilanjan Ghosh, Raul Cordoba, Sarah C Rutherford, Eirini Bournazou, Emily Labriola-Tompkins, Izolda Franjkovic, Evelyne Chesne, Jurriaan Brouwer-Visser, Katharina Lechner, Barbara Brennan, Eveline Nüesch, Mark DeMario, Dominik Rüttinger, Martin Kornacker, Martin Hutchings
Phase 1b study of the BET protein inhibitor RO6870810 with venetoclax and rituximab in patients with diffuse large B-cell lymphoma. Blood advances 5 (22) (2021)
Martin Hutchings
A small change makes a big difference in Hodgkin lymphoma. Blood 132 (21) (2019)

Martin Hutchings.css-eqlu8i{font-size:small;padding-left:4px;} (M Hutchings)

Publication Activity (10 Years)

Top Topics

Top Venues

Martin Hutchings (M Hutchings)